1. Home
  2. ORRF vs DAWN Comparison

ORRF vs DAWN Comparison

Compare ORRF & DAWN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ORRF
  • DAWN
  • Stock Information
  • Founded
  • ORRF 1919
  • DAWN 2018
  • Country
  • ORRF United States
  • DAWN United States
  • Employees
  • ORRF N/A
  • DAWN N/A
  • Industry
  • ORRF Major Banks
  • DAWN Biotechnology: Pharmaceutical Preparations
  • Sector
  • ORRF Finance
  • DAWN Health Care
  • Exchange
  • ORRF Nasdaq
  • DAWN Nasdaq
  • Market Cap
  • ORRF 666.6M
  • DAWN 624.8M
  • IPO Year
  • ORRF N/A
  • DAWN 2021
  • Fundamental
  • Price
  • ORRF $33.30
  • DAWN $7.12
  • Analyst Decision
  • ORRF Buy
  • DAWN Strong Buy
  • Analyst Count
  • ORRF 2
  • DAWN 7
  • Target Price
  • ORRF $42.00
  • DAWN $27.86
  • AVG Volume (30 Days)
  • ORRF 129.3K
  • DAWN 1.4M
  • Earning Date
  • ORRF 10-21-2025
  • DAWN 11-04-2025
  • Dividend Yield
  • ORRF 3.25%
  • DAWN N/A
  • EPS Growth
  • ORRF 198.98
  • DAWN N/A
  • EPS
  • ORRF 3.78
  • DAWN N/A
  • Revenue
  • ORRF $247,296,000.00
  • DAWN $187,638,000.00
  • Revenue This Year
  • ORRF $30.74
  • DAWN $12.88
  • Revenue Next Year
  • ORRF N/A
  • DAWN $48.27
  • P/E Ratio
  • ORRF $8.78
  • DAWN N/A
  • Revenue Growth
  • ORRF 66.90
  • DAWN 2190.50
  • 52 Week Low
  • ORRF $25.57
  • DAWN $5.64
  • 52 Week High
  • ORRF $41.99
  • DAWN $16.76
  • Technical
  • Relative Strength Index (RSI)
  • ORRF 46.24
  • DAWN 46.89
  • Support Level
  • ORRF $32.94
  • DAWN $7.15
  • Resistance Level
  • ORRF $34.94
  • DAWN $7.86
  • Average True Range (ATR)
  • ORRF 0.93
  • DAWN 0.36
  • MACD
  • ORRF 0.03
  • DAWN -0.04
  • Stochastic Oscillator
  • ORRF 39.20
  • DAWN 18.33

About ORRF Orrstown Financial Services Inc

Orrstown Financial Services Inc is a holding company engaged in commercial banking and trust business, this involves accepting demand, time, and savings deposits and granting loans. The company is also engaged in lending services for commercial, residential, commercial mortgages, construction, municipal, and various forms of consumer lending, and deposit services that include checking, savings, time, and money market deposits. It also provides investment and brokerage services through its Financial Advisors division. The Company earns fees from its deposit clients for transaction-based account maintenance and overdraft services, It also earns wealth management and investment brokerage fees from its contracts with trusts. The company operates in a segment, namely Community Banking.

About DAWN Day One Biopharmaceuticals Inc.

Day One Biopharmaceuticals Inc is a clinical-stage biopharmaceutical company. It is dedicated towards developing and commercializing targeted therapies for patients of all ages with genetically defined cancers. Initially, it focuses on clinical development efforts on pediatric patients living with cancer, a vulnerable population that has been underserved in the recent revolution in targeted therapeutics and immuno-oncology. The product candidate, DAY101, is an oral, brain-penetrant, highly-selective type II pan-rapidly accelerated fibrosarcoma, or pan-RAF, and kinase inhibitor.

Share on Social Networks: